全文获取类型
收费全文 | 4884篇 |
免费 | 113篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 70篇 |
儿科学 | 2044篇 |
妇产科学 | 64篇 |
基础医学 | 253篇 |
口腔科学 | 16篇 |
临床医学 | 467篇 |
内科学 | 565篇 |
皮肤病学 | 22篇 |
神经病学 | 168篇 |
特种医学 | 82篇 |
外科学 | 398篇 |
综合类 | 289篇 |
预防医学 | 260篇 |
眼科学 | 12篇 |
药学 | 205篇 |
1篇 | |
中国医学 | 48篇 |
肿瘤学 | 68篇 |
出版年
2024年 | 19篇 |
2023年 | 78篇 |
2022年 | 163篇 |
2021年 | 199篇 |
2020年 | 154篇 |
2019年 | 288篇 |
2018年 | 234篇 |
2017年 | 101篇 |
2016年 | 105篇 |
2015年 | 91篇 |
2014年 | 250篇 |
2013年 | 204篇 |
2012年 | 122篇 |
2011年 | 169篇 |
2010年 | 139篇 |
2009年 | 126篇 |
2008年 | 138篇 |
2007年 | 140篇 |
2006年 | 100篇 |
2005年 | 59篇 |
2004年 | 35篇 |
2003年 | 22篇 |
2002年 | 19篇 |
2001年 | 22篇 |
2000年 | 20篇 |
1999年 | 15篇 |
1998年 | 11篇 |
1997年 | 10篇 |
1996年 | 9篇 |
1995年 | 6篇 |
1994年 | 8篇 |
1993年 | 4篇 |
1991年 | 4篇 |
1990年 | 4篇 |
1988年 | 6篇 |
1987年 | 4篇 |
1986年 | 4篇 |
1985年 | 176篇 |
1984年 | 213篇 |
1983年 | 54篇 |
1982年 | 179篇 |
1981年 | 195篇 |
1980年 | 166篇 |
1979年 | 167篇 |
1978年 | 165篇 |
1977年 | 136篇 |
1976年 | 153篇 |
1975年 | 97篇 |
1974年 | 133篇 |
1973年 | 110篇 |
排序方式: 共有5032条查询结果,搜索用时 15 毫秒
71.
72.
73.
74.
《Biology of blood and marrow transplantation》2013,19(11):1608-1614
Little information is currently available regarding the pharmacokinetics (PK) of busulfan in infants and small children to help guide decisions for safe and efficacious drug therapy. The objective of this study was to develop an algorithm for individualized dosing of i.v. busulfan in infants and children weighing ≤12 kg, that would achieve targeted exposure with the first dose of busulfan. Population PK modeling was conducted using intensive time-concentration data collected through the routine therapeutic drug monitoring of busulfan in 149 patients from 8 centers. Busulfan PK was well described by a 1-compartment base model with linear elimination. The important clinical covariates affecting busulfan PK were actual body weight and age. Based on our model, the predicted clearance of busulfan increases approximately 1.7-fold between 6 weeks to 2 years of life. For infants age <5 months, the model-predicted doses (mg/kg) required to achieve a therapeutic concentration at steady state of 600-900 ng/mL (area under the curve range, 900-1350 μM·min) were much lower compared with standard busulfan doses of 1.1 mg/kg. These results could help guide clinicians and inform better dosing decisions for busulfan in young infants and small children undergoing hematopoietic cell transplantation. 相似文献
75.
BackgroundCystic fibrosis is a degenerative disease characterized by progressive epithelial secretory gland dysfunction associated with repeated respiratory infections. Bacterial infections are very frequent in children with cystic fibrosis, but because rapidMethodsfor screening for the wide variety of potentially involved viruses were unavailable until recently, the frequency of viral presence is unknown. Multiplex PCR enables screening for many viruses involved in respiratory infections.ObjectivesThis study aimed to evaluate the frequency of viruses and bacteria in respiratory specimens from children with cystic fibrosis and to clarify the incidence and characteristics (seasonality and age of patients) of different viruses detected in children with cystic fibrosis.Study designIn this 2-year prospective study, we obtained paired nasopharyngeal-swab and sputum specimens from children with cystic fibrosis during clinical respiratory examinations separated by at least 14 days. We analyzed viruses in nasopharyngeal-swab specimens with multiplex PCR and bacteria in sputum with standard methods.ResultsWe analyzed 368 paired specimens from 33 children. We detected viruses in 154 (41.8%) and bacteria in 132 (35.9%). Bacteria were commoner in spring and summer; viruses were commoner in autumn and winter. In every season, Staphylococcus aureus was the commonest bacteria and rhinovirus was the commonest virus. Nearly all infections with Haemophilus influenzae occurred in autumn and winter.Viruses were more prevalent in children <5 years old, and bacteria were more prevalent in children ≥12 years old.ConclusionsMultiplex PCR screening for respiratory viruses is feasible in children with cystic fibrosis; the clinical implications of screening warrant further study. 相似文献
76.
Although most of nerve injuries associated with Monteggia fracture-dislocation in children are neurapraxias and will recover spontaneously after conservative treatment,surgical exploration of the invol... 相似文献
77.
Mortada Hassan El-Shabrawi Naglaa Mohamed Kamal Alanani 《World journal of gastroenterology : WJG》2013,19(44):7880-7888
Hepatitis C virus(HCV)is a major health burden infecting 170-210 million people worldwide.Additional 3-4millions are newly-infected annually.Prevalence of pediatric infection varies from 0.05%-0.36%in the United States and Europe;up to 1.8%-5.8%in some developing countries.The highest prevalence occurs in Egypt,sub-Saharan Africa,Amazon basin and Mongolia.HCV has been present in some populations for several centuries,notably genotypes 1 and 2 in West Africa.Parenteral anti-schistosomal therapy practiced in the 1960s until the early 1980s had spread HCV infection throughout Egypt.Parenteral acquisition of HCV remains a major route for infection among Egyptian children.Insufficient screening of transfusions,unsterilized injection equipment and re-used needles and syringes continue to be major routes of HCV transmission in developing countries,whereas vertical transmission and adolescent high-risk behaviors(e.g.,injection drug abuse)are the major routes in developed countries.The risk of vertical transmission from an infected mother to her unborn/newborn infant is approximately 5%.Early stages of HCV infection in children do not lead to marked impairment in the quality of life nor to cognitive,behavioral or emotional dysfunction;however,caregiver stress and family system strain may occur.HCV slowly progresses to serious complications as cirrhosis(1%-2%)and hepatocellular carcinoma(HCC)especially in the presence of risk factors as hemolytic anemias,obesity,treated malignancy,and concomitant human immune deficiency and/or hepatitis B virus co-infection.HCV vaccine remains elusive to date.Understanding the immune mechanisms in patients who successfully cleared the infection is essential for vaccine development.The pediatric standard of care treatment consists of pegylated interferon-α2a or b plus ribavirin for 24-48 wk.The new oral direct acting antivirals,approved for adults,need further evaluation in children.Sustained virologic response varies depending on the viral load,genotype,duration of infection,degree of am 相似文献
78.
79.
80.
Otto G. Thilenius MD PhD FACC Dolores Vitullo MD Saroja Bharati MD FACC Julia Luken MD John J. Lamberti MD FACC Constantine Tatooles MD FACC Maurice Lev MD FACC Ian Carr MD Rene A. Arcilla MD FACC 《The American journal of cardiology》1979,44(7):1339-1343
Clinical and angiographic or autopsy data, or both, on three children with a subdivided left atrium (cor triatriatum) and an associated endocardial cushion defect are reviewed. (One child had ostium primum defect, and two had complete atrioventricular [A-V] canal.) A fourth patient demonstrates the difficulties in differentiating subdivided left atrium from supravalve mitral stenosis in the presence of an endocardial cushion defect. The clinical findings are greatly influenced by the endocardial cushion defect. A pressure gradient between the pulmonary wedge and (left or right) ventricular end-diastolic pressures in patients with an endocardial cushion defect indicates pulmonary venous obstruction and should alert one to the possibility of these combined lesions. The exact diagnosis is made with injections of angiographic contrast medium into the proximal and distal left atrial chambers, to document the respective relations of the pulmonary veins, left atrial appendage and A-V valves to these atrial chambers. All three patients with an endocardial cushion defect and a subdivided left atrium had an associated patent ductus arteriosus. The common association of subdivided left atrium with intracardiac, pulmonary venous and aortic anomalies is again demonstrated. 相似文献